At FDA advisory committee meetings, persuasive public comments from patients and clinicians can significantly influence outcomes. This emotional and practical testimony often proves more compelling to panelists than the FDA's complex statistical or data interpretability arguments, especially for diseases with high unmet need.

The 19th-century term "omissional infanticide" powerfully reframes withholding life-saving procedures not as a personal choice, but as an act of lethal inaction. This concept extends from historical smallpox vaccine refusal to modern rejections of routine preventative care like vitamin K shots for newborns, labeling inaction as the weapon.

In response to emotional patient testimony supporting Capricor's Duchenne drug, an FDA official reframed regulatory strictness as a crucial patient safeguard. The argument is that high standards and rejecting drugs with weak data are essential to protect patients from the risks and false hope of ineffective treatments, turning a perceived barrier into a protective measure.

Structure your problem statement as a three-part narrative to create urgency. First, anchor it to a recent "change" the company is undergoing. Then, present your solution as the logical "response." Finally, "contrast" the negative outcome of inaction with the positive outcome of your approach.

Mind Medicine Australia proactively engaged the Department of Veterans Affairs and major health insurers from their inception. They presented the long-term cost savings of effective psychedelic treatment versus chronic care, successfully getting key payors on board to cover costs once the therapies became legal.

The FDA's traditional focus on risk avoidance overlooks the inherent risk of delay. Unnecessary bureaucratic steps, like months of animal trials, prevent dying patients from accessing potentially life-saving treatments. The cost of inaction is measured in lives lost.

A top Australian regulator admitted Mind Medicine Australia's persistent emails and calls drove his staff "crazy." However, this perceived aggression forced the agency to engage on the scientific merits of the case, rather than dismiss it, ultimately leading to the rescheduling of psilocybin and MDMA.

To convince a country to allow its illegal drone operations, Zipline framed the problem in the starkest terms: delivering life-saving blood. The argument was that if a delivery *doesn't* happen, a person will die. This created a powerful moral imperative for regulators to grant an exception.

During a key presentation to 140 Australian regulators, the testimony of a woman whose husband died by suicide after failing to access psychedelic therapy left "not a dry eye in the room." This emotional appeal created the human context that allowed the subsequent scientific data to land effectively.